ArticleThe pharmacogenomics journal2013

Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.

N Simon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.